Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification

被引:155
作者
Ohshima, T [1 ]
Koga, H [1 ]
Shimotohno, K [1 ]
机构
[1] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan
关键词
D O I
10.1074/jbc.M403866200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Covalent modification of many transcription factors with SUMO-1 is emerging as a key role of trans-activational regulation. Here, we demonstrate that peroxisome proliferator-activated receptor (PPAR) gamma, which is a ligand-activated nuclear receptor, is modified by SUMO-1. Sumoylation of PPARgamma mainly occurs at a lysine residue within the activation function 1 domain. Furthermore, we show that the PIAS family proteins, PIAS1 and PIASxbeta, function as E3 ligases (ubiquitin-protein isopeptide ligase) for PPARgamma. PPARgamma interacts directly with PIASxbeta in a ligand-independent manner. Analysis using a PPARgamma mutant with a disrupted sumoylation site shows that modification of PPARgamma by SUMO-1 represses its transcriptional activity. Interestingly, PIASxbeta and Ubc9 enhance the transcriptional activity of PPARgamma independent of PPARgamma sumoylation. Furthermore, PPARgamma ligand-induced apoptosis in a human hepatoblastoma cell line, HepG2, is significantly enhanced by ectopic production of the sumoylation-mutant PPARgamma. These results suggest that the PPARgamma-dependent transactivation pathway seems to be modulated by SUMO-1 modification and may serve as a novel target for apoptosis-induction therapy in cancer cells.
引用
收藏
页码:29551 / 29557
页数:7
相关论文
共 48 条
[1]   Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site [J].
Adams, M ;
Reginato, MJ ;
Shao, DL ;
Lazar, MA ;
Chatterjee, VK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5128-5132
[2]  
Camp HS, 1997, J BIOL CHEM, V272, P10811
[3]   Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9 [J].
Chakrabarti, SR ;
Sood, R ;
Ganguly, S ;
Bohlander, S ;
Shen, ZY ;
Nucifora, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7467-7472
[4]   Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis [J].
Eibl, G ;
Wente, MN ;
Reber, HA ;
Hines, OJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) :522-529
[5]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[6]   Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme [J].
Hahn, SL ;
Criqui, P ;
Wasylyk, B .
ONCOGENE, 1997, 15 (12) :1489-1495
[7]   Protein modification by SUMO [J].
Hay, RT .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (05) :332-333
[8]   SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin [J].
Horie, K ;
Tomida, A ;
Sugimoto, Y ;
Yasugi, T ;
Yoshikawa, H ;
Taketani, Y ;
Tsuruo, T .
ONCOGENE, 2002, 21 (52) :7913-7922
[9]   Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma [J].
Hu, ED ;
Kim, JB ;
Sarraf, P ;
Spiegelman, BM .
SCIENCE, 1996, 274 (5295) :2100-2103
[10]   An E3-like factor that promotes SUMO conjugation to the yeast septins [J].
Johnson, ES ;
Gupta, AA .
CELL, 2001, 106 (06) :735-744